E. V. Bogoslovskaya

Learn More
  • A. L. Sukhanova, N. I. Roudinskii, +11 authors A. F. Bobkov
  • 2005
The pol nucleotide sequences coding for protease and reverse transcriptase were examined to study the frequency of drug resistance mutations in HIV-1 subtype A in Russia. The sample included 141 HIV-infected subjects who had never received antiretroviral drugs before. Primary resistance mutations occurred at a low (less than 1%) frequency, while unusually(More)
Chemokine receptor 5 (CCR5) is one of the two coreceptors that are utilized by the human immunodeficiency virus (HIV) to enter the cell. CCR5 inactivation is considered to be a promising approach to HIV therapy, including gene therapy. RNA interference provides a powerful tool to regulate gene expression and may be utilized to knockdown the CCR5 gene. Three(More)
  • 1